Abstract

Preclinical testing is a vital phase in the drug development process that assesses the safety and efficacy of potential therapeutic candidates before they are tested in humans. This article explores the objectives, methodologies, and significance of preclinical testing, highlighting its role in identifying promising drug candidates and ensuring patient safety. The discussion also addresses the challenges faced during this phase and the innovations that are shaping the future of preclinical research. Understanding preclinical testing is essential for stakeholders in the pharmaceutical industry, regulatory agencies, and the scientific community.